Drug Facts

Manufacturer
L'Oreal USA Products Inc | L'Oreal USA Products, Inc.
Effective date
2026-05-19
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:58:06

Label at a glance#

ProductCeraVe Developed with Dermatologists Itch Relief Moisturizing
Active ingredientPRAMOXINE HYDROCHLORIDE
Label structure10 sections

Dosage and administration

• Adults and children 2 years of age and older:    • apply to affected area not more than 3 to 4 times daily • for use on children 2–12 years old, application should be supervised by an adult

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Pramoxine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Topical antipruritic

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

if you are allergic to any of the ingredients.

When using this product,

OTC - WHEN USING SECTION

avoid contact with eyes. If contact occurs, rinse with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

• condition worsens

• symptoms last more than 7 days or reoccur within a few days.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact Poison Control Centre immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

• Adults and children 2 years of age and older:

   • apply to affected area not more than 3 to 4 times daily

• for use on children 2–12 years old, application should be supervised by an adult

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua, Glycerin, Petrolatum, Cetyl alcohol, Butyrospermum parkii (shea) butter, Cetearyl alcohol, Glyceryl stearate, PEG-100 stearate, Isopropyl
myristate, Stearic acid, Dimethicone, Palmitic acid, Phenoxyethanol, Behentrimonium methosulfate, Xanthan gum, Sodium hydroxide,
Ethylhexylglycerin, Myristic acid, Sodium lauroyl lactylate, Potassium phosphate, Dipotassium phosphate, Disodium EDTA, Tasmannia lanceolata
fruit/leaf extract, Ceramide NP, Ceramide AP, Phytosphingosine, Cholesterol, Carbomer, Hydrolyzed hyaluronic acid, Citric acid, Ceramide EOP.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

jar frontjar frontjar backjar back

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1052684pramoxine HCl 1 % Topical CreamPSN1
1052684pramoxine hydrochloride 10 MG/ML Topical CreamSCD1
1052684pramoxine hydrochloride 1 % Topical CreamSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8Product name120140508
a7051cba-790b-a699-81f8-dbbbdbd9b5acProduct name120140508
da108d9e-edc8-17a3-8c28-3251c6a8acccProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82046-034-01CeraVe Developed with Dermatologists Itch Relief Moisturizing340 g in 1 JARCREAM3401

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82046-03482046-034-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 31 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
522e7455-2817-b1c0-e063-6394a90a8de64c396286-fffe-420d-ba94-91fb73f04a692026-05-19WarningsExact identifier
spl id: 522e7455-2817-b1c0-e063-6394a90a8de6
spl set id: 4c396286-fffe-420d-ba94-91fb73f04a69

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.